Hepatic chemosaturation with melphalan in patients with primary or secondary liver tumors with or without extrahepatic tumor manifestation
CS-PHP induced hepatic disease control in the majority of patients. Extrahepatic tumor manifestation had no significant impact on OS. The relevance of CS-PHP as long-term treatment needs to be validated in future studies.
Authors
- Daniel Seehofer (ORCID: https://orcid.org/0000-0002-7492-8309)
- Christian Girbardt (ORCID: https://orcid.org/0000-0002-7843-9617)
- Sebastian Ebel (ORCID: https://orcid.org/0000-0001-6856-6455)
- Florian Lordick (ORCID: https://orcid.org/0000-0001-8591-9339)
- Timm Denecke (ORCID: https://orcid.org/0000-0003-3313-3208)
- Aaron Schindler (ORCID: https://orcid.org/0009-0001-5245-6048)
- Focke Ziemssen (ORCID: https://orcid.org/0000-0002-3873-0581)
- Manuel Florian Struck (ORCID: https://orcid.org/0000-0002-0070-3406)
- Florian van Bömmel (ORCID: https://orcid.org/0000-0003-2679-0672)
- Rhea Veelken
- Thomas Berg (ORCID: https://orcid.org/0000-0003-0003-6241)
Institutions
- Leipzig University of Applied Sciences (DE)
- University Hospital Leipzig (DE)
- Leipzig University (DE)
Publication Details
- Journal
- ESMO Gastrointestinal Oncology
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1016/j.esmogo.2024.100082
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00